Weighted Average Number of Shares Outstanding, Diluted of PLUS THERAPEUTICS, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
PLUS THERAPEUTICS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • PLUS THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 77,804,612, a 910% increase year-over-year.
  • PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 77,804,612, a 910% increase from 2024.
  • PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 7,700,774, a 145% increase from 2023.
  • PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3,140,925, a 79% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 77,804,612 +70,103,838 +910% 01 Oct 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 107,428,969 +99,573,206 +1268% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 209,154,994 +198,412,070 +1847% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 14,566,724 +10,244,993 +237% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025 2025 Q1
Q4 2024 7,700,774 +4,559,849 +145% 01 Oct 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 7,855,763 +4,630,412 +144% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 10,742,924 +8,233,546 +328% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 4,321,731 +2,001,714 +86% 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025 2025 Q1
Q4 2023 3,140,925 +1,390,575 +79% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 3,225,351 +1,395,907 +76% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 2,509,378 +1,025,723 +69% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 2,320,017 -19,187,044 -89% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 1,750,350 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 1,829,444 -11,434,786 -86% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023 2023 Q3
Q2 2022 1,483,655 -9,813,161 -87% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 21,507,061 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023 2023 Q1
Q3 2021 13,264,230 01 Jul 2021 30 Sep 2021 10-Q 20 Oct 2022 2022 Q3
Q2 2021 11,296,816 01 Apr 2021 30 Jun 2021 10-Q 21 Jul 2022 2022 Q2
Q3 2016 20,493,840 +9,962,576 +95% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 14,778,616 +4,954,078 +50% 01 Apr 2016 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q3 2015 10,531,264 -69,898,797 -87% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 9,824,538 -66,858,105 -87% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q3 2014 80,430,061 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 76,682,643 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2012 57,484,990 +5,490,282 +11% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 53,504,030 01 Oct 2011 31 Dec 2011 10-K/A 07 Sep 2012 2011 FY
Q3 2011 53,900,250 +7,994,670 +17% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 52,411,642 +7,115,677 +16% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 51,994,708 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q3 2010 45,905,580 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011 2011 Q3
Q2 2010 45,295,965 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011 2011 Q2

PLUS THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 77,804,612 +70,103,838 +910% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 7,700,774 +4,559,849 +145% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 3,140,925 +1,390,575 +79% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 1,750,350 -10,338,836 -86% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 12,089,186 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023 2022 FY
2011 53,504,030 +7,556,064 +16% 01 Jan 2011 31 Dec 2011 10-K/A 07 Sep 2012 2011 FY
2010 45,947,966 01 Jan 2010 31 Dec 2010 10-K/A 07 Sep 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.